2023 · Therapeutic drug monitoring · paywalled
Volumetric Absorptive Microsampling for the Therapeutic Drug Monitoring of Everolimus in Patients Who Have Undergone Liver Transplant
Yoo et al.
The finding, in our words
VAMS capillary samples from 32 liver transplant recipients showed strong agreement with venous blood for everolimus measurement, with a correlation of r squared 0.92 and no proportional or constant bias on Bland Altman analysis. No effect of haematocrit or sampling time was observed, supporting VAMS as a virtually painless decentralised alternative to venous draws for immunosuppressant monitoring in transplant patients.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.